Director/PDMR Shareholding

RNS Number : 4897B
Byotrol PLC
30 January 2020
 

 

 

Byotrol plc

("Byotrol", the "Company" or the "Group")

 

Director/PDMR Shareholding

 

 

Byotrol Plc (AIM:BYOT), the anti-microbial technology company, announces that on 30 January 2020, John Langlands, Non-Executive Chairman of the Company, and Nic Hellyer, Chief Financial Officer of the Company, purchased 1,000,000 and 500,000 ordinary shares of 0.25p each ("Ordinary Shares") respectively at prices between 1.79 and 1.83 pence per Ordinary Share, respectively (the "Purchases").


Following the Purchases, Mr. Langlands has an interest in 9,000,000 Ordinary Shares representing approximately 2.04 per cent. of the total voting rights of the Company and Nic Hellyer has an interest in 500,000 Ordinary Shares representing approximately 0.11 per cent. of the total voting rights of the Company.

 

 

 

Enquiries:

                                                                                                              

David Traynor - Chief Executive, Byotrol plc                                                          01925 742 000

David Paton - Investor Relations                                                                            07714 190 474

finnCap Ltd                                                                                                              020 7110 0500
(NominateAdviser & Broker)

Geoff Nash/Teddy Whiley Corporate Finance

Richard Chambers - Corporate Broking

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

 

Noteto Editors: 

Byotrol plc (BYOT.L), quoted on AIM, is a specialist developer of antimicrobial technologies, identifying, developing, formulating and commercialising cutting-edge antimicrobial solutions.

Our patented suite of technologies delivers powerful, broad-spectrum efficacy, optimised against commonly-occurring and industry-specific pathogens.

Founded in 2005, the Company seeks to develop and commercialise advanced antimicrobial technologies that create easier, safer and cleaner lives for everyone.

For more information, please go to www.byotrol.co.uk

 

 

Accordingly, the Company makes the following announcement and notification in accordance with the EU Market Abuse Regulation (No 596/2014):

 

1.    

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

John Langlands

2.    

Reason for the Notification

a)

Position/status

Non-Executive Chairman

b)

Initial notification/Amendment

Initial

3.    

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Byotrol Plc

b)

LEI

213800AJMTSTIPA59A34

4.    

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

ordinary shares of 0.25p each

Identification code

GB00B0999995

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Volume - 250,000

Price - 1.7975 pence

Volume - 500,000

Price - 1.83 pence

Volume - 250,000

Price - 1.79 pence

d)

Aggregated information:

Volume - 1,000,000

Aggregated price - 1.81 pence

e)

Date of the transaction

30 January 2020

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 

1.    

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Nic Hellyer

2.    

Reason for the Notification

a)

Position/status

Chief Financial Officer

b)

Initial notification/Amendment

Initial

3.    

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Byotrol Plc

b)

LEI

213800AJMTSTIPA59A34

4.    

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

ordinary shares of 0.25p each

Identification code

GB00B0999995

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Volume - 278,164

Price - 1.7975 pence

Volume - 221,836

Price - 1.799 pence

d)

Aggregated information:

Volume - 500,000

Aggregated Price - 1.798 pence

e)

Date of the transaction

30 January 2020

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHDZGFMVGRGGZM
UK 100

Latest directors dealings